Treatment Program Details
Medication-assisted treatment is an important part of Caron’s patient-centered treatment plans as it reduces cravings, anxiety, withdrawal symptoms, and post-acute withdrawal syndrome. The use of medications to help manage these physical issues allows the individual to focus their attention on their psychological, emotional, and spiritual needs through therapy, group meetings, and recovery support groups.
Caron uses MAT in combination with interdisciplinary interventions, including evidence-based therapies like dialectical behavior therapy (DBT) and cognitive behavioral therapy (CBT). We also assess each patient for mental health issues and other healthcare needs, such as chronic pain, so that we can address them.
Patients have the choice to continue with medication-assisted treatment for maintenance. Post-acute withdrawal syndrome can recur up to a year after treatment and interfere with an individual’s ability to engage in their recovery practices and supports.
These are some of the medications Caron uses:
- Buprenorphine is an opioid medication that, according to the National Institute on Drug Abuse (NIDA), reduces cravings and withdrawal symptoms in people with an opioid use disorder and can be tolerated relatively well by most people.
- Vivitrol® or naltrexone blocks opioids and alcohol from producing euphoric effects. Vivitrol should only be taken under the guidance of a licensed and experienced medical addiction treatment provider.
- Suboxone® combines buprenorphine and naloxone, prevents cravings, and helps people to get treatment and move into recovery. Like buprenorphine, it is also noted by NIDA as an effective medication to treat opioid use disorder. Suboxone® is a registered trademark of Indivior UK Limited. Caron Treatment Center is not affiliated with Indivior UK Limited or its affiliates ("Indivior"), and any reference to it or its intellectual property is for informational purposes only and is not endorsed or sponsored by Indivior.
